2013Chinese journal of integrated traditional and Western medicineRequires access

Clinical observation on ulcerative colitis treated by oral sulfasalazine and retention enema of Xianbaitang.

Dabin Ren

Open publisher page 0 citations

Abstract

[Objective]To evaluate the clinical efficacy of Xianbaitang retention enema and sulfasalazine on ulcerative colitis.[Methods]Eighty patients with ulcerative colitis were divided randomly into 2 groups:30 patients were taken as control group treated with sulfasalazine oral and 50 patients were taken as enema group treated with traditional Chinese medicine enema and oral sulfasalazine.After two weeks treatment,defecation frequency,rectal bleeding,relief of abdominal pain in all patients were observed.Colonoscopy was performed.[Results]The remission time of clinical symptoms of enema group was shorter than that of control group(P0.01).The endoscopic relieving rate was 73.33% in control group and 96% in enema group(P0.01).The total effective rate was 92% in enema group and 73.33% in control group(P0.01).[Conclusion]Combination of sulfasalazine with Xianbaitang by retention enema has a high early remission rate for ulcerative colitis compared to the usage of sulfasalazine alone.

About this research paper

What this paper is about

[Objective]To evaluate the clinical efficacy of Xianbaitang retention enema and sulfasalazine on ulcerative colitis.[Methods]Eighty patients with ulcerative colitis were divided randomly into 2 groups:30 patients were taken as control group treated with sulfasalazine oral and 50 patients were taken as enema group treated with traditional Chinese medicine enema and oral sulfasalazine.After two weeks treatment,defecation frequency,rectal bleeding,relief of abdominal pain in all patients were observed.Colonoscopy was performed.[Results]The remission time of clinical symptoms of enema group was shorter than that of control group(P0.01).The endoscopic relieving rate was 73.33% in control group and 96% in enema group(P0.01).The total effective rate was 92% in enema group and 73.33% in control group(P0.01).[Conclusion]Combination of sulfasalazine with Xianbaitang by retention enema has a high early remission rate for ulcerative colitis compared to the usage of sulfasalazine alone.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

[Objective]To evaluate the clinical efficacy of Xianbaitang retention enema and sulfasalazine on ulcerative colitis.[Methods]Eighty patients with ulcerative colitis were divided randomly into 2 groups:30 patients were taken as control group treated with sulfasalazine oral and 50 patients were taken as enema group treated with traditional Chinese medicine enema and oral sulfasalazine.After two weeks treatment,defecation frequency,rectal bleeding,relief of abdominal pain in all patients were observed.Colonoscopy was performed.[Results]The remission time of clinical symptoms of enema group was shorter than that of control group(P0.01).The endoscopic relieving rate was 73.33% in control group and 96% in enema group(P0.01).The total effective rate was 92% in enema group and 73.33% in control group(P0.01).[Conclusion]Combination of sulfasalazine with Xianbaitang by retention enema has a high early remission rate for ulcerative colitis compared to the usage of sulfasalazine alone.

Key concepts: Sulfasalazine, Enema, Medicine, Ulcerative colitis, Gastroenterology, Internal medicine, Colonoscopy, Mesalazine

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical observation on ulcerative colitis treated by oral sulfasalazine and retention enema of Xianbaitang. — Research Paper | ScholarLens